Hartford Financial Management Inc. decreased its stake in shares of Danaher Co. (NYSE:DHR – Free Report) by 5.8% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 15,116 shares of the conglomerate’s stock after selling 926 shares during the quarter. Hartford Financial Management Inc.’s holdings in Danaher were worth $4,203,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also made changes to their positions in the stock. nVerses Capital LLC acquired a new stake in Danaher in the second quarter valued at approximately $25,000. CarsonAllaria Wealth Management Ltd. purchased a new stake in shares of Danaher during the 2nd quarter worth $25,000. MFA Wealth Advisors LLC acquired a new position in shares of Danaher during the second quarter worth $51,000. Financial Connections Group Inc. acquired a new stake in Danaher during the 2nd quarter worth $51,000. Finally, Western Pacific Wealth Management LP purchased a new stake in Danaher in the 1st quarter valued at $55,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Insider Transactions at Danaher
In related news, SVP Georgeann Couchara sold 952 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $268.37, for a total transaction of $255,488.24. Following the completion of the sale, the senior vice president now directly owns 4,212 shares of the company’s stock, valued at $1,130,374.44. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 11.10% of the stock is owned by company insiders.
Wall Street Analysts Forecast Growth
Read Our Latest Research Report on Danaher
Danaher Stock Performance
NYSE:DHR opened at $245.66 on Friday. The firm’s 50-day moving average is $267.38 and its 200-day moving average is $260.32. The company has a market cap of $177.44 billion, a price-to-earnings ratio of 46.88, a PEG ratio of 4.45 and a beta of 0.83. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. Danaher Co. has a 52-week low of $188.75 and a 52-week high of $281.70.
Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating the consensus estimate of $1.57 by $0.14. The firm had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.02 EPS. Equities research analysts anticipate that Danaher Co. will post 7.51 earnings per share for the current year.
Danaher Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s dividend payout ratio (DPR) is currently 20.61%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Stories
- Five stocks we like better than Danaher
- Consumer Staples Stocks, Explained
- Top Nuclear Stocks Thriving on Soaring Energy Demand
- Best Stocks Under $5.00
- Apple Earnings – When Really Good Just Isn’t Good Enough
- 3 Fintech Stocks With Good 2021 Prospects
- Starbucks Stock Primed for Growth Under New CEO Niccol’s Vision
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.